Abstract
A 56-year-old male is evaluated during a scheduled follow-up appointment in the pain clinic for back and radicular pain that persists after an L3-5 laminectomy 2 years ago. His analgesic regimen is oxycodone controlled release, 60 mg BID (twice a day), with oxycodone immediate release, 15 mg TID (3 times a day), as needed, along with gabapentin, amitriptyline, and lidocaine patches. The patient is not satisfied with this regimen, because his pain prevents him from returning to work. He asks to have the dose of controlled release oxycodone increased because its efficacy has decreased over time. Lumbar epidural steroid injections and medial branch nerve blocks have not helped. Physical therapy offers only minimal pain relief. The patient consults with a psychiatrist for mild depression. After a recent consultation, he was offered a revision procedure by an orthopedic spine surgeon, but the patient is reluctant to accept, given the poor outcome from the first surgical intervention. The resident evaluating the patient is unsure of the next step: increase opioids? Repeat surgery? Other treatment options?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
North RB, Kumar K, Wallace MS, Henderson JM, Shipley J, Hernandez J, et al. Spinal cord stimulation versus re-operation in patients with failed back surgery syndrome: an international multicenter randomized controlled trial (EVIDENCE study). Neuromodulation. 2011;14(4):330–5 (discussion 335–6).
Veizi E, Hayek S. Interventional therapies for chronic low back pain. Neuromodulation. 2014;17:31–45.
Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1–2):179–88.
Wilkes D. Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiency. J Pain Res. 2014;7:571–7.
Turner J, Sears J, Loeser J. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systemic review of effectiveness and complications. Clin J Pain. 2007;23:180–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Anitescu, M., Shah-Doshi, N. (2017). What are the Risks and Benefits of Spinal Cord Stimulators and Intrathecal Pumps?. In: Scher, C., Clebone, A., Miller, S., Roccaforte, J., Capan, L. (eds) You’re Wrong, I’m Right. Springer, Cham. https://doi.org/10.1007/978-3-319-43169-7_104
Download citation
DOI: https://doi.org/10.1007/978-3-319-43169-7_104
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43167-3
Online ISBN: 978-3-319-43169-7
eBook Packages: MedicineMedicine (R0)